Ledger.Open graph →

SEC Form D · Amendment · filed January 10, 2025

Circle Pharma, Inc

Offering

$117.4M

Sold

$92.4M

Exemption

Rule 506(b)

Industry

Other

Location

SOUTH SAN FRANCISCO, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Paul H. Park · SOUTH SAN FRANCISCO, CAExec James H. Evangelista · SOUTH SAN FRANCISCO, CADirector Thilo H. Schroeder · SOUTH SAN FRANCISCO, CADirector Matthew P. Jacobson · SOUTH SAN FRANCISCO, CADirector Stephen H. Kelsey · SOUTH SAN FRANCISCO, CADirector John Josey · SOUTH SAN FRANCISCO, CADirector Walter H. Moos · SOUTH SAN FRANCISCO, CADirector David J. Earp · SOUTH SAN FRANCISCO, CAExec · Director Stephen H. Kelsey · SOUTH SAN FRANCISCO, CADirector Paul H. Park · SOUTH SAN FRANCISCO, CAExec James H. Evangelista · SOUTH SAN FRANCISCO, CADirector Matthew P. Jacobson · SOUTH SAN FRANCISCO, CADirector John Josey · SOUTH SAN FRANCISCO, CADirector Walter H. Moos · SOUTH SAN FRANCISCO, CADirector David J. Earp · SOUTH SAN FRANCISCO, CAExec · Director Thilo H. Schroeder · SOUTH SAN FRANCISCO, CADirector Marques Colston · Fargo, NDDirector Andrew S. Hughes · Pleasanton, CADirector Ronald Zazworsky, Jr · Birmingham, ALDirector Stephen P. Reaves · Los Angeles, CADirector Douglas Barnett · LEHI, UTDirector Tyler Hogge · LEHI, UTExec · Director Todd Pedersen · LEHI, UTDirector Reno Mendenhall · LEHI, UTExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗